Resistance to piperaquine has been associated with the amplification of the plasmepsin II gene in Cambodia. None of the 175 African isolates that we analyzed had plasmepsin II gene amplification (piperaquine 50% inhibitory concentration ranged from 0.94 to 137.5 nM), suggesting there is a low prevalence of piperaquine reduced susceptibility in Africa. Additionally, the few isolates with reduced susceptibility to piperaquine did not harbor amplification of the plasmepsin II gene.
Keywords: Plasmodium falciparum; antimalarial drug; in vitro; malaria; molecular marker; piperaquine; plasmepsin II gene; resistance.
Copyright © 2018 American Society for Microbiology.